Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Quinazoline. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel metal-free electrochemical route for quinazoline intermediates. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing partners globally seeking scalable solutions.
Patent CN101575319A details a greener route for Lapatinib intermediates, eliminating toxic chlorinating agents for significant cost reduction and supply chain reliability.
Patent CN112778219A reveals a green ionic liquid method for quinazoline-2,4-dione. Offers cost reduction and supply chain reliability for pharma intermediates.
Patent CN115490643A details a safe one-pot synthesis for fluquinconazole intermediates, offering significant cost reduction and supply chain reliability for agrochemical manufacturers.
Patent CN111454222A details a metal-free, one-step synthesis of quinazoline diones using CO2, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN108003141A reveals a safer alfuzosin route. Achieve cost reduction in pharmaceutical intermediates manufacturing with stable yields and scalable processes.
Patent CN102584721B reveals a mild triphosgene-based route for 2,4-dichloroquinazoline derivatives, offering significant cost reduction in API manufacturing and improved safety.
Patent CN103965120A details novel quinazoline synthesis for EGFR inhibitors. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Patent CN108264489B reveals a green catalytic method for quinazolines using water-soluble Ir/Ru complexes, offering significant cost reduction and supply chain reliability.
Patent CN113461617A reveals a metal-free visible light method for N-heterocycles. Offers cost reduction and high purity for pharmaceutical intermediate manufacturing supply chains.
Novel solvent-free synthesis of anticancer intermediate CN102911177A. High yield, green chemistry, scalable for API manufacturing.
Discover the green synthesis of fenazaquin via CN102558073A. This novel route eliminates solid waste, reduces costs in agrochemical manufacturing, and ensures high-purity supply.
Patent CN104557737B details a high-yield Pd-catalyzed route for quinazoline intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN109721554A reveals novel quinazoline derivatives for bacterial blight control. Discover cost-effective manufacturing and supply chain advantages for agrochemical intermediates.
Novel Boc-protection strategy for high-purity Raltitrexed intermediate. Reduces side reactions, improves yield, ensures supply chain stability for pharma manufacturing.
Patent CN104003946A details a high-purity synthesis route for Erlotinib impurity, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN119080783A reveals efficient synthesis for organic semiconductor materials. Achieve high purity and yield with reduced catalyst consumption for supply chain stability.
Discover the novel Canertinib synthesis via CN103242244A. A streamlined, cost-effective route for high-purity pharmaceutical intermediates suitable for industrial scale-up.
Patent CN116217497B reveals a novel photocatalytic route for 2-perfluoroalkyl quinazolines. Discover cost-effective, scalable pharmaceutical intermediate manufacturing solutions.
Patent CN103232400A discloses a solvent-free rare earth catalyzed route for quinazoline-2-thiones, offering high yields and simplified purification for pharmaceutical intermediates.